Other languages iSpecimen Inc.

Equities

ISPC

US45032V1089

Market Closed - Nasdaq Other stock markets 01:30:00 29/06/2024 am IST			5-day change	1st Jan Change
0.309 ^USD	-1.87%		-17.73%	-38.27%

03/06	Wall Street Set to Open Slightly Higher Monday as Investors Await Key Manufacturing Data for May	MT
03/06	Top Premarket Decliners	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Wall Street Set to Open Slightly Higher Monday as Investors Await Key Manufacturing Data for May	03/06
Top Premarket Decliners	03/06
ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
ISpecimen Inc. Announces the Board Changes	27/03
ISpecimen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
ISpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research	23/01
Ispecimen Inc. Announces Executive Changes	22/12
ISpecimen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02/11
ISpecimen Inc. Provides Revenue Guidance for Third Quarter 2023	23/23/23
ISpecimen Inc. Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers	28/23/28
Ispecimen Expands Provider Network to Enhance Support for Women's Health Research	13/23/13
ISpecimen to Reduce Headcount by 20% as Part of Restructuring	07/23/07
ISpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers	16/23/16
ISpecimen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	02/23/02
ISpecimen Inc. Receives A Letter of Resignation from Christopher Ianelli to Resign as A Director	08/23/08
ISpecimen Inc.Â Adds Thirteen New Biospecimen Suppliers to its Proprietary Marketplace Throughout the First Half of 2023	06/23/06
ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	04/23/04
Top Premarket Gainers	22/23/22
ISpecimen Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/23/14
ISpecimen Appoints Eric Langlois as Chief Revenue Officer	24/23/24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages iSpecimen Inc.

Equities

ISPC

US45032V1089

Other languages

Filters